Literature DB >> 19069365

Prevalence of CYP2C19 gene polymorphisms in the Puerto Rican population: a preliminary report.

Jorge Duconge, Carmen L Cadilla, Jessica Y Renta, Pamela Silén-Rivera, Paola Piovanetti, Rafael García-Berdecía, Liza M Castro-Rosario, Shalom Monzón, Linet Vélez, Guillermo Rosas, Jhon A Guerra, Pedro J Santiago-Borrero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19069365      PMCID： PMC2748933     

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN： 0738-0658            Impact factor:   0.705


× No keyword cloud information.
  7 in total

Review 1.  Individual and ethnic differences in CYP2C19 activity in Chinese populations.

Authors:  Y Shu; H H Zhou
Journal:  Acta Pharmacol Sin       Date:  2000-03       Impact factor: 6.150

2.  Designing physiogenomic studies.

Authors:  Theodore R Holford; Andreas Windemuth; Gualberto Ruaño
Journal:  Pharmacogenomics       Date:  2006-03       Impact factor: 2.533

Review 3.  Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.

Authors:  D S Streetman; J S Bertino; A N Nafziger
Journal:  Pharmacogenetics       Date:  2000-04

4.  Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.

Authors:  S M De Morais; G R Wilkinson; J Blaisdell; U A Meyer; K Nakamura; J A Goldstein
Journal:  Mol Pharmacol       Date:  1994-10       Impact factor: 4.436

5.  The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.

Authors:  S M de Morais; G R Wilkinson; J Blaisdell; K Nakamura; U A Meyer; J A Goldstein
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

6.  Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population.

Authors:  Wei-Xing Shi; Shu-Qing Chen
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

7.  BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping.

Authors:  Arnold Oliphant; David L Barker; John R Stuelpnagel; Mark S Chee
Journal:  Biotechniques       Date:  2002-06       Impact factor: 1.993
  7 in total
  9 in total

Review 1.  Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors:  I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

Review 2.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

Review 3.  Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.

Authors:  Karla Claudio-Campos; Jorge Duconge; Carmen L Cadilla; Gualberto Ruaño
Journal:  Drug Metab Pers Ther       Date:  2015-06

Review 4.  Implementing genotype-guided antithrombotic therapy.

Authors:  Richard L Seip; Jorge Duconge; Gualberto Ruaño
Journal:  Future Cardiol       Date:  2010-05

5.  Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.

Authors:  Idaliz Rodríguez-Escudero; Julio A Cedeño; Ileana Rodríguez-Nazario; Gledys Reynaldo-Fernández; Leyanis Rodríguez-Vera; Niretzy Morales; Braulio Jiménez-Vélez; Gualberto Ruaño; Jorge Duconge
Journal:  J Am Coll Clin Pharm       Date:  2020-05-02

6.  Frequencies of Functional Polymorphisms in Three Pharmacokinetic Genes of Clinical Interest within the Admixed Puerto Rican Population.

Authors:  Carmelo Orengo-Mercado; Bianca Nieves; Lizbeth López; Nabila Vallés-Ortiz; Jessicca Y Renta; Pedro J Santiago-Borrero; Carmen L Cadilla; Jorge Duconge
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2013-03-27

Review 7.  Pharmacogenetics of healthy volunteers in Puerto Rico.

Authors:  Karla Claudio-Campos; Carmelo Orengo-Mercado; Jessicca Y Renta; Muriel Peguero; Ricardo García; Gabriel Hernández; Susan Corey; Carmen L Cadilla; Jorge Duconge
Journal:  Drug Metab Pers Ther       Date:  2015-12

8.  Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population.

Authors:  Dagmar F Hernandez-Suarez; Mariana R Botton; Stuart A Scott; Matthew I Tomey; Mario J Garcia; Jose Wiley; Pedro A Villablanca; Kyle Melin; Angel Lopez-Candales; Jessicca Y Renta; Jorge Duconge
Journal:  Pharmgenomics Pers Med       Date:  2018-06-08

9.  Clinical Relevant Polymorphisms Affecting Clopidogrel Pharmacokinetics and Pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program.

Authors:  Dagmar F Hernandez-Suarez; Jonnalie C Tomassini-Fernandini; Angelica Cuevas; Anyelis N Rosario-Berrios; Héctor J Nuñez-Medina; Dariana Padilla-Arroyo; Nannette Rivera; Jennifer Liriano; Rocio K Vega-Roman; Jessicca Y Renta; Kyle Melin; Jorge Duconge
Journal:  Int J Environ Res Public Health       Date:  2018-05-30       Impact factor: 3.390
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.